Clinical Trial Update: Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC [Phase 1]

View source ↗

Summary

Phase Ib trial of a multivalent autophagosome vaccine with or without a GITR agonist, combined with anti-PD-1 immunotherapy, for head and neck squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Anti-PD-1 immunotherapy
• Autophagosome vaccine
• GITR agonist

Snippet

Sponsor: Providence Health & Services | Conditions: Cancer of the Head and Neck | Phase 1 | Status: RECRUITING